Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age

BACKGROUND: Dalbavancin is a novel lipoglycopeptide antibiotic that has potent in vitro activity against Gram-positive microorganisms. METHODS: We performed a phase 1, open-label, multi-center study to investigate the pharmacokinetics (PK) and safety of a single-dose of intravenous dalbavancin in ho...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Infect Dis J
Egile Nagusiak: Gonzalez, Daniel, Bradley, John S., Blumer, Jeffrey, Yogev, Ram, Watt, Kevin M., James, Laura P., Palazzi, Debra L., Bhatt-Mehta, Varsha, Sullivan, Janice E., Zhang, Li, Murphy, Jennifer, Ussery, Xilla T., Puttagunta, Sailaja, Dunne, Michael W., Cohen-Wolkowiez, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5468484/
https://ncbi.nlm.nih.gov/pubmed/28060045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001538
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak